Department of Dermatology, University of Sfax, Sfax, Tunisia.
Anatompathology Department, Hospital of Habib Bourguiba, Sfax, Tunisia.
Int J Dermatol. 2022 Nov;61(11):1380-1384. doi: 10.1111/ijd.16278. Epub 2022 May 24.
Erysipeloid cutaneous leishmaniasis (ECL) is known as the chronic form of cutaneous leishmaniasis (CL). However, keeping its clinical presentation in view, there is a need to revisit this form of the disease.
To describe ECL in view of clinical features and treatment modalities.
We include a case series seen in Sfax (Southern Tunisia) from January 2017 to January 2021. All patients clinically suggestive and laboratory confirmed with a diagnosis of CL were registered. Patients of all age groups and of either gender having cutaneous lesions resembling erysipela on the face were included in the study. Different demographic features of the patients and clinical aspects were identified. Descriptive statistics were used for analysis.
Of 1300 registered patients with CL, 40 (3%) were diagnosed as ECL. Ages ranged from 15 to 65 years, and duration of lesions varied from 15 to 180 days. All patients had lesions over the face. Clinically, a painful infiltrated inflammatory placard of the central facial area with a butterfly shape was observed in 14 cases, as well as zones of the cheekbone (11 cases), cheekbone and nose (5 cases), cheekbone and eyelid (8 cases), and cheekbone with ear (2 cases). Several therapeutic methods were prescribed with a sufficient result with no recurrence.
ECL is a rare presentation that typically occurs on the face, looking like erysipelas, in patients who are native from an endemic region of CL.
类丹毒样皮肤利什曼病（ECL）被认为是皮肤利什曼病（CL）的慢性形式。然而，鉴于其临床表现，有必要重新审视这种疾病。
描述 ECL 的临床特征和治疗方法。
我们纳入了 2017 年 1 月至 2021 年 1 月在苏塞（突尼斯南部）观察到的病例系列。所有临床疑似且实验室确诊为 CL 的患者均被登记。所有年龄组和性别均包括有类似丹毒样面部皮肤损害的患者。研究中确定了患者的不同人口统计学特征和临床方面。使用描述性统计进行分析。
在 1300 例登记的 CL 患者中，有 40 例（3%）被诊断为 ECL。年龄从 15 岁到 65 岁不等，病变持续时间从 15 天到 180 天不等。所有患者均有面部病变。临床上，在 14 例患者中观察到中央面部区域呈蝶形的疼痛性浸润性炎症斑块，以及颧骨区（11 例）、颧骨和鼻子（5 例）、颧骨和眼睑（8 例）和颧骨和耳朵（2 例）。开了几种治疗方法，结果令人满意，没有复发。
ECL 是一种罕见的表现，通常发生在面部，在来自 CL 流行地区的患者中，其外观类似丹毒。
